Back

Handheld ultrasound device with continuous-wave doppler capability: is it feasible?

9 December 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: e-posters session - Echocardiography Technology EACVI Premium Access EuroEcho 2021

About the speaker

Photo
Doctor Vasileios Sachpekidis

Hospital Papageorgiou, Thessaloniki (Greece)

290 More presentations in this session

Presentation thumbnail
Association of 24-hour ambulatory central aortic pressure and left atrium-ventriculo-arterial interactions
Doctor N. Georgieva (Sofia, BG)
Abstract Slides
Presentation thumbnail
Breast cancer patients presenting with cardiotoxicity - risk factors and role of cardioprotective drugs
Doctor M. Martins de Carvalho (Porto, PT)
Abstract Slides
Presentation thumbnail
Global longitudinal strain and territorial longitudinal strain in determining myocardial viability in out of window period anterior wall myocardial infarction patients
Slides
Presentation thumbnail
Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study
Doctor F. Gonzalez Teston (Jerez de la Frontera, ES)
Abstract Slides
Presentation thumbnail
Correlation between the left ventricular strain and the severity of coronary atherosclerosis in patients with coronary artery disease
Doctor R. Alieva (Tashkent, UZ)
Abstract Slides

Access the full session

Session thumbnail
e-posters session - Echocardiography

The Event

Event poster

EuroEcho 2021

9 December 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Assessing handheld echocardiography: can it reliably detect HVD and LVSD compared to comprehensive echo?
11 December 2024
thumbnail
Congress Presentation
Monitoring of cerebral high intensity transient signals during catheter interventions and surgery for congenital heart disease in infants using NeoDoppler
11 December 2020
thumbnail
Congress Presentation
Doppler echocardiography: physical principles, assumptions & implications
12 December 2024
thumbnail
Congress Presentation
Quality-of-life improvement of the 100 patients treated over the Valvosoft prospective, multi-centre, single-arm first-in-human and pivotal studies: 12 month follow-up.
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources